Translational Medecine and Neurogenetics, IGBMC-Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.
J Neurochem. 2013 Aug;126 Suppl 1:65-79. doi: 10.1111/jnc.12219.
The development and use of animal and cellular models of Friedreich ataxia (FRDA) are essential requirements for the understanding of FRDA disease mechanisms and the investigation of potential FRDA therapeutic strategies. Although animal and cellular models of lower organisms have provided valuable information on certain aspects of FRDA disease and therapy, it is intuitive that the most useful models are those of mammals and mammalian cells, which are the closest in physiological terms to FRDA patients. To date, there have been considerable efforts put into the development of several different FRDA mouse models and relevant FRDA mouse and human cell line systems. We summarize the principal mammalian FRDA models, discuss the pros and cons of each system, and describe the ways in which such models have been used to address two of the fundamental, as yet unanswered, questions regarding FRDA. Namely, what is the exact pathophysiology of FRDA and what is the detailed genetic and epigenetic basis of FRDA?
开发和利用弗里德赖希共济失调(FRDA)的动物和细胞模型是理解 FRDA 疾病机制和研究潜在 FRDA 治疗策略的必要要求。尽管较低等生物的动物和细胞模型为 FRDA 疾病和治疗的某些方面提供了有价值的信息,但直观地说,最有用的模型是哺乳动物和哺乳动物细胞的模型,它们在生理上与 FRDA 患者最为接近。迄今为止,已经投入了相当大的努力来开发几种不同的 FRDA 小鼠模型以及相关的 FRDA 小鼠和人细胞系系统。我们总结了主要的哺乳动物 FRDA 模型,讨论了每个系统的优缺点,并描述了这些模型如何用于解决 FRDA 尚未解决的两个基本问题。即,FRDA 的确切病理生理学是什么,以及 FRDA 的详细遗传和表观遗传基础是什么?